|Jean Armengaud, PhD|
Atomic Energy and Alternative Energies Commission | CEA - Life Sciences Frédéric-Joliot Institute (Joliot)
|Erin Baker, PhD|
North Carolina State University
|Anne Bendt, PhD|
National University of Singapore
Anne K Bendt studied Biology focusing on marine biotechnology (Greifswald University, Germany), followed by a PhD in Biochemistry (Cologne University, Germany) employing proteomics and transcriptomics. Driven by her fascination for infectious diseases, she joined the National University of Singapore (NUS) in 2004 to develop lipidomics tools for tuberculosis studies. She is now a Principal Investigator at the Life Sciences Institute, NUS, focussing on translation of mass spec technologies into clinical applications, and serving as the Associate Director of the Singapore Lipidomics Incubator (SLING) taking care of operations and commercialization.
|Clifton Fagerquist, PhD|
U.S. Department of Agriculture
Dr. Clifton K. Fagerquist received his Ph.D. in physical chemistry from UCLA in 1994 where he studied stable and metastable gas phase clusters using fast atom bombardment and sector-field mass spectrometry. After post-doctoral research at UC Berkeley and two years directing a mass spectrometry facility at University of Minnesota, Minneapolis, he joined the Agricultural Research Service (ARS) in Philadelphia. He then moved to the ARS facility in Albany, California where he has been using advanced mass spectrometry and proteomic techniques to characterize foodborne pathogens and their toxins.
|Timothy Garrett, PhD|
University of Florida College of Medicine
Dr. Garrett has over 20 years of experience in the field of mass spectrometry spanning both instrument and application development. He received his PhD from the University of Florida, under Dr. Richard A. Yost, working on the first imaging mass spectrometry-based ion trap instrument. He has also developed MALDI-based approaches to analyze proteins in bacteria and small molecules in tissue specimens. His current interests include the translation of LC-HRMS, MALDI, DESI and LMJSSP in metabolomics to clinical diagnostics. He is an Associate Professor in the Department of Pathology at the University of Florida, and an Associate Director for the Southeast Center for Integrated Metabolomics (SECIM).
|Ronda Greaves, PhD, MAACB, FFSc (RCPA)|
Victorian Clinical Genetics Services
|Daniel Holmes, MD|
University of British Columbia, St Paul's Hospital
Daniel Holmes did his undergraduate training in Chemistry and Physics at the University of Toronto before deciding to pursue medicine as a career. He attended medical school at the University of British Columbia where pathology became his area of major interest. The strong influence of his academic mentors led him to enter the Medical Biochemistry residency training program at UBC. This allowed him to use his background knowledge of chemistry in application to medicine. Areas of clinical interest are diagnostic lipidology/endocrinology and research interests are in the utilization of mathematics and computer diagnostics to laboratory medicine.
|Julijana Ivanisevic, PhD|
University of Lausanne
|Randy Julian, PhD|
|Gabi Kastenmüller, PhD, Dr. rer. nat|
Helmholtz Zentrum München
|Mark Kushnir, PhD|
Mark Kushnir is Scientific Director, Mass Spectrometry R&D at ARUP Institute for Clinical and Experimental Pathology and Adjunct Assistant Professor at the Department of Pathology, University of Utah School of Medicine. He received PhD in Analytical Chemistry from Uppsala University (Uppsala, Sweden); his main areas of interest include development, application and clinical evaluation of novel mass spectrometry based clinical diagnostic methods for small molecule, protein and peptide biomarkers. He is author/coauthor of over 100 scientific peer reviewed publications.
|Chia-Ni Lin, PhD|
Chang Gung Memorial Hospital
|Kara Lynch, PhD|
University of California, San Francisco
|Gwen McMillin, PhD|
Dr. McMillin is a professor of pathology at the University of Utah School of Medicine. She received her PhD in pharmacology and toxicology from the University of Utah and is certified by the American Board of Clinical Chemistry in clinical chemistry and toxicological chemistry. She is a member of ARUP’s R&D Executive Committee, and is actively involved in professional associations such as the International Association of Therapeutic Drug Monitoring and Clinical Chemistry (IATDMCT), the American Association for Clinical Chemistry (AACC), and the College of American Pathologists (CAP). Her primary interests include detection of neonatal drug exposures, pain management, and clinical applications and implementation of pharmacogenomics.
|Kathrina Rentsch, PhD, Prof. Dr. sc. nat|
|Jody van den Ouweland, PhD|
Jody van den Ouweland studied Chemistry at Leiden University and received his PhD degree in 1994 on the discovery of a type 2 diabetic subtype (MIDD). Areas of clinical interest are diabetes, endocrinology and clinical biomarkers. In the area of analytical chemistry his focus is on mass spectrometric and chromatographic methods for quantitative measurement of low molecular weight biomarkers, such as vitamins, steroids and amino acids. He is a member of the Dutch working group of Clinical Mass Spectrometry, member of the MSACL EU Scientific Board, and Editorial Board member of the Clinical Mass Spectrometry Journal.
|Grace van der Gugten|
University of British Columbia, St Paul's Hospital
Grace van der Gugten is the LC-MS/MS Assay Development Specialist in the clinical chemistry laboratory at St Paul’s Hospital in Vancouver, BC, Canada. She is passionate about mass spectrometry and that this technology is utilized in the clinical lab to help patients. She has a strong interest in troubleshooting and making challenging assays work for the busy St Paul’s mass spectrometry laboratory.
|Elizabeth Want, PhD|
Imperial College London
|Manfred Wuhrer, PhD, Prof. dr.|
Leiden University Medical Center
Manfred Wuhrer studied biochemistry at Regensburg University, and did a PhD in parasite glycobiology at Giessen University, both Germany. Since 2003 he is at the Leiden University Medical Center, the Netherlands, where he is currently heading the Center for Proteomics and Metabolomics. His key interests are the development of mass spectrometric methods for studying proteins and carbohydrates, and their application in biomedical research on cancer, autoimmune and infections diseases, with the aim of impacting patient care.
|Victoria Zhang, PhD|
University of Rochester Medical Center
Started my career in proteomics for biomarker discovery from graduate school where I also got my bioinformatic minor to handle all the data i generated. later moved to clinical chemistry and continue to focus on mass spectrometry applications in clinical labs. Started a division within AACC to establish a platform in AACC for this technology - also naively without being aware of the history between MSACL and AACC in this topic at the time :-). had numerous short courses, workshops and symposia and conference in the past few years for mass spectrometry. would love to continue to do what I can to further this field.